SCHEMBL1853499

SCHEMBL1853499

CCOC(=O)C(=O)N(Cc1ccc(C(=O)OCc2ccccc2)cc1)Cc1ccc(C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 4/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TSHR P16473 1/20 0.45
TMEM97 Q5BJF2 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
POLB P06746 1/20 0.44
GPBAR1 Q8TDU6 1/20 0.44
GAA P10253 1/20 0.44
RAB9A P51151 1/20 0.44
SLC2A1 P11166 1/20 0.43
TP53 P04637 1/20 0.43
CETP P11597 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1854059 0.91 MAPT (0.56) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL1856298 0.85 SRD5A2 (0.50) KMT2AMEN1MAPTALDH1A1
SCHEMBL1851321 0.82 SRD5A2 (0.47) KMT2AMEN1MAPTALDH1A1
SCHEMBL1856143 0.82 ALDH1A1 (0.55) KMT2AMEN1MAPTALDH1A1SMN1; SMN2
SCHEMBL1853690 0.82 HDAC3 (0.58) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL4317895 0.82 PTGES (0.48) KMT2AMEN1ALDH1A1LMNASLC2A1
SCHEMBL20831000 0.81 KMT2A (0.69) KMT2AMEN1MAPTALDH1A1HPGD
SCHEMBL1856984 0.81 MAPT (0.41) KMT2AMEN1MAPTCETP
SCHEMBL1853170 0.79 MAPT (0.48) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL1855559 0.79 NPSR1 (0.45) KMT2AMEN1MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470102-B1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) MERCK SERONO SA (CH) 2011-05-25 EP disclosed
US-7592477-B2 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2009-09-22 US disclosed
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) APPLIED RESEARCH SYSTEMS ARS (NL) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) PTPRS, PTPA, PTPMT1 KMT2A 740/4885MEN1 2496/4885MAPT 4575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.